C4 Therapeutics, Inc.

North America Legal Chronicle. January 9, 2024

C4 Therapeutics’ License and Research Collaboration with Merck

By Leila Ahmed

Wilson Sonsini Goodrich & Rosati advised C4 Therapeutics on the transaction. C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC) announced that it has entered into an exclusive license...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

North America Legal Chronicle. June 12, 2023

C4 Therapeutics’ Exclusive Licensing Agreement with Betta Pharmaceuticals

By Pietro Martinoia

Goodwin Procter served as legal counsel to C4T, and Han Kun Law Offices served as legal counsel to Betta. C4 Therapeutics, Inc. announced its exclusive licensing agreement...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Tex-Tech Industries’ $165 Million Acquisition of Fiber Materials

GSR III Acquisition Corp.’s US$200 Million Initial Public Offering

Kodiak Gas Services’ $189.57 Million Common Stock Offering

‘Mercado Crédito XXIX’ Financial Trusts’s US$43 Million Issuance

YPF Luz’s US$420 Million Notes Issuance

360 Energy Solar’s US$22 Million Green Notes Issuance

Peach Property Group’s Divestment of Residential Portfolio

Zorlu Enerji’s US$200 Million Sustainability-Linked Eurobond Issuance

Bilbolaget’s Land Acquisition

Tamweely’s EGP 5 Billion Securitization Program

TE H2, CIP, and A.P. Moller Capital’s Developmente Of Large-Scale Green Hydrogen Project In Morocco

Camusat Holding’s €81 Million Mezzanine Investment Round

Commercial Bank of Dubai’s US$500 Million Bond Issuance

Medianova’s Investment Round

Lulu Retail Holdings Plc’s $1.72 Billion IPO On ADX

AGC Automotive (Thailand) Co., Ltd. v. Renewable Energy for Thai People Co., Ltd.

Profectus Capital’s Non-Convertible Debentures Issuance

NBL and LK Group’s Investment in WNBL

King & Spalding Continues Antitrust Growth with Addition of Partner Olivier N. Antoine in New York

Real Estate Partner Brian Crist Joins Barnes & Thornburg

Paul, Weiss Welcomes Two Leading Life Science & Technology Litigators in New York

The Diarra Ruling On The Transfer Of Players Within The EU And The FIFA Regulation On The Status And Transfer Of Players

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

King & Spalding Continues Antitrust Growth with Addition of Partner Olivier N. Antoine in New York

Real Estate Partner Brian Crist Joins Barnes & Thornburg

Paul, Weiss Welcomes Two Leading Life Science & Technology Litigators in New York

C4 Therapeutics’ License and Research Collaboration with Merck

Standard 1 Year Membership Required

C4 Therapeutics’ Exclusive Licensing Agreement with Betta Pharmaceuticals

Standard 1 Year Membership Required